methotrexate
Rheumatoid arthritis drug methotrexate reduces joint damage progression in hand osteoarthritis
Methotrexate appears to lower the progression of joint damage of erosive hand osteoarthritis and may even facilitate bone remodelling according to a small study presented at an international conference. Continue reading
Fatigue and gastric side effects top methotrexate complaints
The most common adverse events associated with methotrexate in people with rheumatoid arthritis and psoriatic arthritis are fatigue and gastrointestinal complaints, according to a study presented at an international conference. Continue reading
People on tofacitinib with low disease activity may be able to safely withdraw methotrexate
Rheumatoid arthritis patients who achieve low disease activity with tofacitinib and methotrexate can safely withdraw methotrexate without fear of worsening disease activity, scientists report in The Lancet Rheumatology. Continue reading
Arthritis drug methotrexate seems to reduce blood cancer symptoms
A simple arthritis drug – methotrexate – can reduce symptoms for people with polycythemia vera (PV) and essential thrombocythemia (ET), two types of blood cancer. Continue reading
Future rheumatoid arthritis treatment could focus on DMARDs over methotrexate
The role of disease-modifying antirheumatic drugs (DMARDs) may evolve even further in rheumatoid arthritis treatment after a review of the evidence is published by the European League against Rheumatism. Continue reading
